Suchergebnisse - "Bover, Mateo"

PubPharm (6)

1

Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma : A Meta-Analysis

enthalten in: The oncologist | 2023

von Yarza, R. | Bover, M. | Herrera-Juarez, M. | +4

2

Current approach and novel perspectives in nasopharyngeal carcinoma : the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer

enthalten in: Journal of experimental & clinical cancer research : CR | 2021

von Yarza, R. | Bover, M. | Agulló-Ortuño, M. | +1

3

Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer

enthalten in: Journal of experimental & clinical cancer research | 2021

von Yarza, R. | Bover, M. | Agulló-Ortuño, M. | +1

4

On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy

enthalten in: Journal for immunotherapy of cancer | 2021

von Nenclares, P. | Gunn, L. | Soliman, H. | +10

5

SARS-CoV-2 infection in cancer patients undergoing active treatment : analysis of clinical features and predictive factors for severe respiratory failure and death

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Yarza, R. | Bover, M. | Paredes, D. | +12

CommentIn: Eur J Cancer. 2020 Oct;138:225-227. - PMID 32927375

6

Four-Year Lasting Sustained Complete Response After Nivolumab in a Patient With Non-Small-Cell Lung Cancer and Confirmed Leptomeningeal Carcinomatosis : Changing the Paradigm

enthalten in: Clinical lung cancer | 2020

von Bover, M. | Yarza, R. | Docampo, L.

1
[1]